These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28717948)

  • 21. Non-Arsenical heartworm adulticidal therapy using topical moxidectin-imidacloprid and doxycycline: A prospective case series.
    Ames MK; VanVranken P; Evans C; Atkins CE
    Vet Parasitol; 2020 Jun; 282():109099. PubMed ID: 32450463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs.
    von Samson-Himmelstjerna G; Epe C; Schimmel A; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S114-5. PubMed ID: 12928872
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs.
    Genchi M; Vismarra A; Lucchetti C; Viglietti A; Crosara S; Gnudi G; Quintavalla C; Schaper R; Kramer L
    Vet Parasitol; 2019 Sep; 273():11-16. PubMed ID: 31442887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to Giannelli et al.--comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Traversa D; Famigli Bergamini P; Fracassi F; Pampurini F; Boari A
    Parasitol Res; 2014 Mar; 113(3):1091-2. PubMed ID: 24407917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
    Bianciardi P; Otranto D
    Vet Parasitol; 2005 Apr; 129(1-2):89-93. PubMed ID: 15817208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and duration of action of oral fluralaner and spot-on moxidectin/imidacloprid in cats infested with Lynxacarus radovskyi.
    Han HS; Noli C; Cena T
    Vet Dermatol; 2016 Dec; 27(6):474-e127. PubMed ID: 27870235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG; Bowman DD; Slone RL; Travis LE
    Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot trial evaluating the efficacy of a 10% imidacloprid/2.5% moxidectin spot-on formulation in the treatment of natural nasal capillariosis in dogs.
    Veronesi F; Morganti G; Di Cesare A; Schaper R; Traversa D
    Vet Parasitol; 2014 Feb; 200(1-2):133-8. PubMed ID: 24365240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA
    Di Cesare A; Morelli S; Morganti G; Simonato G; Veronesi F; Colombo M; Berlanda M; Lebon W; Gallo M; Beugnet F; Traversa D
    Parasit Vectors; 2021 Mar; 14(1):143. PubMed ID: 33676579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.
    Hellmann K; Heine J; Braun G; Paran-Dobesova R; Svobodova V
    Parasitol Res; 2011 Aug; 109 Suppl 1():S77-86. PubMed ID: 21739377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Giannelli A; Daugschies A; Dantas-Torres F; Otranto D
    Parasitol Res; 2013 Nov; 112(11):3979-80. PubMed ID: 24096604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a single topical application of Advantage Multi (= Advocate) Topical Solution (10% imidocloprid + 2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis.
    Conboy G; Hare J; Charles S; Settje T; Heine J
    Parasitol Res; 2009 Aug; 105 Suppl 1():S49-54. PubMed ID: 19575225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).
    Taweethavonsawat P; Chungpivat S; Satranarakun P; Traub RJ; Schaper R
    Parasitol Res; 2010 May; 106(6):1499-502. PubMed ID: 20349196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
    Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
    Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
    Loft KE; Willesen JL
    Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 1% spot-on against Otodectes cynotisin cats.
    Fourie LJ; Kok DJ; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S112-3. PubMed ID: 12928871
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
    Heine J; Krieger K; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid.
    Huang HP; Lien YH
    Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.